SCHEMBL21452022

SCHEMBL21452022

N#Cc1ccc(C2(Cl)CCCCC2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.40
TP53 P04637 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MAPT P10636 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
PGR P06401 2/20 0.35
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
CYP11B2 P19099 1/20 0.34
HSD11B1 P28845 1/20 0.34
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
SLC6A9 P48067 1/20 0.33
POLB P06746 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452525 0.82 PGR (0.40) CA1CA2CNR2PGRMAOA
SCHEMBL3392422 0.78 MEN1 (0.42)
SCHEMBL21452018 0.77 CYP19A1 (0.40) CYP19A1TP53CNR1CNR2PGR
SCHEMBL23490891 0.77 CYP11B2 (0.33) MAPTCYP11B2TSHRSMN1; SMN2POLB
SCHEMBL21452011 0.77 CYP11B2 (0.38) CYP19A1CA1CA2PGRCYP11B2
SCHEMBL21452002 0.75 SLC22A12 (0.38) PGRCYP2D6
SCHEMBL21452416 0.74 SLC6A3 (0.44) MAOAMAOBHSD11B1
SCHEMBL21452253 0.72 CYP19A1 (0.36) CYP19A1TP53MAPTCNR1CNR2
SCHEMBL28167765 0.72 MEN1 (0.44)
SCHEMBL30586005 0.69 ESR1 (0.52) CYP19A1CA2PGRMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171487-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI JIANHE PHARMACEUTICAL & TECHNOLOGY CO. LTD. (CN) 2021-06-10 US disclosed
EP-3778579-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Jianhe Pharmaceutical & Technology Co. Ltd. (CN) 2021-02-17 EP disclosed
WO-2019192602-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海键合医药科技有限公司 2019-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171487-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF CYP4F11, PAH, COMT CYP19A1 386/4885TP53 3367/4885CA1 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.